nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—ADRA2A—Brimonidine—glaucoma	0.122	0.152	CbGbCtD
Benzphetamine—ADRA2A—Apraclonidine—glaucoma	0.122	0.152	CbGbCtD
Benzphetamine—ADRA1A—Apraclonidine—glaucoma	0.117	0.146	CbGbCtD
Benzphetamine—ADRA2A—Dipivefrin—glaucoma	0.0973	0.122	CbGbCtD
Benzphetamine—ADRA1A—Dipivefrin—glaucoma	0.0933	0.117	CbGbCtD
Benzphetamine—SLC6A2—Clonidine—glaucoma	0.0561	0.0702	CbGbCtD
Benzphetamine—ADRA2A—Clonidine—glaucoma	0.0505	0.0633	CbGbCtD
Benzphetamine—ADRA1A—Clonidine—glaucoma	0.0485	0.0607	CbGbCtD
Benzphetamine—CYP3A4—Pilocarpine—glaucoma	0.0219	0.0274	CbGbCtD
Benzphetamine—CYP3A4—Brinzolamide—glaucoma	0.0172	0.0215	CbGbCtD
Benzphetamine—CYP3A4—Dorzolamide—glaucoma	0.0166	0.0208	CbGbCtD
Benzphetamine—CYP3A4—Methazolamide—glaucoma	0.0148	0.0185	CbGbCtD
Benzphetamine—CYP3A4—Acetazolamide—glaucoma	0.0118	0.0148	CbGbCtD
Benzphetamine—CYP3A4—Clonidine—glaucoma	0.0107	0.0134	CbGbCtD
Benzphetamine—Digestion impaired—Diclofenamide—glaucoma	0.0055	0.0381	CcSEcCtD
Benzphetamine—Digestion impaired—Methazolamide—glaucoma	0.00507	0.035	CcSEcCtD
Benzphetamine—Digestion impaired—Acetazolamide—glaucoma	0.00351	0.0243	CcSEcCtD
Benzphetamine—Digestion impaired—Brinzolamide—glaucoma	0.00316	0.0219	CcSEcCtD
Benzphetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00274	0.0482	CbGpPWpGaD
Benzphetamine—SLC6A3—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00252	0.0442	CbGpPWpGaD
Benzphetamine—Tachycardia—Dipivefrin—glaucoma	0.0025	0.0173	CcSEcCtD
Benzphetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00201	0.0353	CbGpPWpGaD
Benzphetamine—Sweating—Carbachol—glaucoma	0.00193	0.0133	CcSEcCtD
Benzphetamine—SLC18A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.0019	0.0334	CbGpPWpGaD
Benzphetamine—Hypersensitivity—Dipivefrin—glaucoma	0.00189	0.0131	CcSEcCtD
Benzphetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00185	0.0324	CbGpPWpGaD
Benzphetamine—Nausea—Physostigmine—glaucoma	0.00179	0.0124	CcSEcCtD
Benzphetamine—POR—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00177	0.0311	CbGpPWpGaD
Benzphetamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00163	0.0287	CbGpPWpGaD
Benzphetamine—Palpitations—Metipranolol—glaucoma	0.00156	0.0108	CcSEcCtD
Benzphetamine—Tremor—Diclofenamide—glaucoma	0.00151	0.0104	CcSEcCtD
Benzphetamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00145	0.0256	CbGpPWpGaD
Benzphetamine—Palpitations—Carteolol—glaucoma	0.00145	0.01	CcSEcCtD
Benzphetamine—SLC18A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.00139	0.0245	CbGpPWpGaD
Benzphetamine—Palpitations—Levobunolol—glaucoma	0.00137	0.00944	CcSEcCtD
Benzphetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00135	0.0237	CbGpPWpGaD
Benzphetamine—SLC6A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00128	0.0225	CbGpPWpGaD
Benzphetamine—Anorexia—Diclofenamide—glaucoma	0.00125	0.00865	CcSEcCtD
Benzphetamine—Hyperhidrosis—Carbachol—glaucoma	0.00124	0.00856	CcSEcCtD
Benzphetamine—Insomnia—Carteolol—glaucoma	0.00121	0.00835	CcSEcCtD
Benzphetamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.0012	0.021	CbGpPWpGaD
Benzphetamine—Dyspepsia—Diclofenamide—glaucoma	0.00116	0.00799	CcSEcCtD
Benzphetamine—Sweating—Dorzolamide—glaucoma	0.00115	0.00797	CcSEcCtD
Benzphetamine—Anorexia—Methazolamide—glaucoma	0.00115	0.00797	CcSEcCtD
Benzphetamine—Decreased appetite—Diclofenamide—glaucoma	0.00114	0.00789	CcSEcCtD
Benzphetamine—SLC6A3—Amine compound SLC transporters—SLC6A13—glaucoma	0.00113	0.0199	CbGpPWpGaD
Benzphetamine—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00113	0.00784	CcSEcCtD
Benzphetamine—Dyspepsia—Carbachol—glaucoma	0.00113	0.0078	CcSEcCtD
Benzphetamine—Sweating—Pilocarpine—glaucoma	0.00109	0.00753	CcSEcCtD
Benzphetamine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.00106	0.0187	CbGpPWpGaD
Benzphetamine—Dyspepsia—Methazolamide—glaucoma	0.00106	0.00736	CcSEcCtD
Benzphetamine—Hypersensitivity—Metipranolol—glaucoma	0.00106	0.00734	CcSEcCtD
Benzphetamine—Decreased appetite—Methazolamide—glaucoma	0.00105	0.00726	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Methazolamide—glaucoma	0.00104	0.00721	CcSEcCtD
Benzphetamine—Palpitations—Apraclonidine—glaucoma	0.00101	0.007	CcSEcCtD
Benzphetamine—Urticaria—Levobunolol—glaucoma	0.001	0.00693	CcSEcCtD
Benzphetamine—Psychotic disorder—Betaxolol—glaucoma	0.001	0.00692	CcSEcCtD
Benzphetamine—Hypersensitivity—Carteolol—glaucoma	0.000984	0.0068	CcSEcCtD
Benzphetamine—Palpitations—Bimatoprost—glaucoma	0.000982	0.00679	CcSEcCtD
Benzphetamine—Urticaria—Methazolamide—glaucoma	0.00096	0.00664	CcSEcCtD
Benzphetamine—Dizziness—Metipranolol—glaucoma	0.000953	0.00659	CcSEcCtD
Benzphetamine—Agitation—Acetazolamide—glaucoma	0.000942	0.00651	CcSEcCtD
Benzphetamine—SLC6A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000937	0.0165	CbGpPWpGaD
Benzphetamine—Hypersensitivity—Levobunolol—glaucoma	0.000929	0.00643	CcSEcCtD
Benzphetamine—Headache—Metipranolol—glaucoma	0.000903	0.00624	CcSEcCtD
Benzphetamine—SLC6A2—Monoamine Transport—SLC6A1—glaucoma	0.00089	0.0156	CbGpPWpGaD
Benzphetamine—Dizziness—Carteolol—glaucoma	0.000883	0.0061	CcSEcCtD
Benzphetamine—Diarrhoea—Carbachol—glaucoma	0.000877	0.00606	CcSEcCtD
Benzphetamine—Sweating—Clonidine—glaucoma	0.00087	0.00601	CcSEcCtD
Benzphetamine—Palpitations—Brimonidine—glaucoma	0.000869	0.00601	CcSEcCtD
Benzphetamine—Dizziness—Diclofenamide—glaucoma	0.000868	0.006	CcSEcCtD
Benzphetamine—Tremor—Brinzolamide—glaucoma	0.000865	0.00598	CcSEcCtD
Benzphetamine—Diarrhoea—Levobunolol—glaucoma	0.000863	0.00597	CcSEcCtD
Benzphetamine—Nausea—Metipranolol—glaucoma	0.000856	0.00592	CcSEcCtD
Benzphetamine—Agitation—Brinzolamide—glaucoma	0.000849	0.00587	CcSEcCtD
Benzphetamine—Dizziness—Carbachol—glaucoma	0.000847	0.00586	CcSEcCtD
Benzphetamine—Insomnia—Apraclonidine—glaucoma	0.000846	0.00585	CcSEcCtD
Benzphetamine—Headache—Carteolol—glaucoma	0.000836	0.00578	CcSEcCtD
Benzphetamine—Dizziness—Levobunolol—glaucoma	0.000834	0.00577	CcSEcCtD
Benzphetamine—Tremor—Pilocarpine—glaucoma	0.000832	0.00575	CcSEcCtD
Benzphetamine—Palpitations—Dorzolamide—glaucoma	0.00083	0.00574	CcSEcCtD
Benzphetamine—SLC6A3—Amine compound SLC transporters—SLC6A1—glaucoma	0.00083	0.0146	CbGpPWpGaD
Benzphetamine—ADRA1A—Endothelin Pathways—MYLK—glaucoma	0.000828	0.0146	CbGpPWpGaD
Benzphetamine—Diarrhoea—Methazolamide—glaucoma	0.000827	0.00572	CcSEcCtD
Benzphetamine—Palpitations—Travoprost—glaucoma	0.000827	0.00572	CcSEcCtD
Benzphetamine—Headache—Diclofenamide—glaucoma	0.000822	0.00569	CcSEcCtD
Benzphetamine—Insomnia—Bimatoprost—glaucoma	0.00082	0.00567	CcSEcCtD
Benzphetamine—Palpitations—Brinzolamide—glaucoma	0.000816	0.00564	CcSEcCtD
Benzphetamine—Agitation—Pilocarpine—glaucoma	0.000816	0.00564	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000807	0.00558	CcSEcCtD
Benzphetamine—Headache—Carbachol—glaucoma	0.000803	0.00555	CcSEcCtD
Benzphetamine—Dyspepsia—Bimatoprost—glaucoma	0.000798	0.00552	CcSEcCtD
Benzphetamine—Nausea—Carteolol—glaucoma	0.000793	0.00548	CcSEcCtD
Benzphetamine—Headache—Levobunolol—glaucoma	0.00079	0.00546	CcSEcCtD
Benzphetamine—SLC6A3—Monoamine Transport—SLC6A1—glaucoma	0.000788	0.0139	CbGpPWpGaD
Benzphetamine—Palpitations—Pilocarpine—glaucoma	0.000785	0.00542	CcSEcCtD
Benzphetamine—Tachycardia—Brimonidine—glaucoma	0.000784	0.00542	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000783	0.00541	CcSEcCtD
Benzphetamine—Nausea—Diclofenamide—glaucoma	0.00078	0.00539	CcSEcCtD
Benzphetamine—Dizziness—Latanoprost—glaucoma	0.000774	0.00535	CcSEcCtD
Benzphetamine—Nausea—Carbachol—glaucoma	0.000761	0.00526	CcSEcCtD
Benzphetamine—Sweating—Betaxolol—glaucoma	0.000757	0.00524	CcSEcCtD
Benzphetamine—Headache—Methazolamide—glaucoma	0.000757	0.00524	CcSEcCtD
Benzphetamine—Nausea—Levobunolol—glaucoma	0.000749	0.00518	CcSEcCtD
Benzphetamine—Tachycardia—Travoprost—glaucoma	0.000745	0.00515	CcSEcCtD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000744	0.0131	CbGpPWpGaD
Benzphetamine—Hyperhidrosis—Dorzolamide—glaucoma	0.000741	0.00513	CcSEcCtD
Benzphetamine—Dyspepsia—Acetazolamide—glaucoma	0.000736	0.00509	CcSEcCtD
Benzphetamine—Tachycardia—Brinzolamide—glaucoma	0.000736	0.00509	CcSEcCtD
Benzphetamine—Headache—Latanoprost—glaucoma	0.000733	0.00507	CcSEcCtD
Benzphetamine—Anorexia—Dorzolamide—glaucoma	0.000731	0.00505	CcSEcCtD
Benzphetamine—Decreased appetite—Acetazolamide—glaucoma	0.000727	0.00503	CcSEcCtD
Benzphetamine—Insomnia—Brimonidine—glaucoma	0.000726	0.00502	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000722	0.00499	CcSEcCtD
Benzphetamine—Nausea—Methazolamide—glaucoma	0.000718	0.00496	CcSEcCtD
Benzphetamine—Tachycardia—Pilocarpine—glaucoma	0.000707	0.00489	CcSEcCtD
Benzphetamine—Dyspepsia—Brimonidine—glaucoma	0.000707	0.00489	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pilocarpine—glaucoma	0.0007	0.00484	CcSEcCtD
Benzphetamine—Insomnia—Dorzolamide—glaucoma	0.000694	0.0048	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000693	0.00479	CcSEcCtD
Benzphetamine—Anorexia—Pilocarpine—glaucoma	0.000691	0.00478	CcSEcCtD
Benzphetamine—Hypersensitivity—Apraclonidine—glaucoma	0.000689	0.00476	CcSEcCtD
Benzphetamine—Insomnia—Brinzolamide—glaucoma	0.000682	0.00471	CcSEcCtD
Benzphetamine—Dyspepsia—Dorzolamide—glaucoma	0.000675	0.00467	CcSEcCtD
Benzphetamine—Dyspepsia—Travoprost—glaucoma	0.000672	0.00465	CcSEcCtD
Benzphetamine—Decreased appetite—Dorzolamide—glaucoma	0.000667	0.00461	CcSEcCtD
Benzphetamine—Urticaria—Acetazolamide—glaucoma	0.000665	0.0046	CcSEcCtD
Benzphetamine—Tremor—Clonidine—glaucoma	0.000664	0.00459	CcSEcCtD
Benzphetamine—Dyspepsia—Brinzolamide—glaucoma	0.000664	0.00459	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Travoprost—glaucoma	0.000659	0.00456	CcSEcCtD
Benzphetamine—Insomnia—Pilocarpine—glaucoma	0.000655	0.00453	CcSEcCtD
Benzphetamine—Decreased appetite—Brinzolamide—glaucoma	0.000655	0.00453	CcSEcCtD
Benzphetamine—Agitation—Clonidine—glaucoma	0.000652	0.0045	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000651	0.0045	CcSEcCtD
Benzphetamine—Diarrhoea—Apraclonidine—glaucoma	0.00064	0.00442	CcSEcCtD
Benzphetamine—Dyspepsia—Pilocarpine—glaucoma	0.000638	0.00441	CcSEcCtD
Benzphetamine—Decreased appetite—Pilocarpine—glaucoma	0.00063	0.00436	CcSEcCtD
Benzphetamine—Palpitations—Clonidine—glaucoma	0.000627	0.00433	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000626	0.00433	CcSEcCtD
Benzphetamine—Sweating—Timolol—glaucoma	0.000619	0.00428	CcSEcCtD
Benzphetamine—Dizziness—Apraclonidine—glaucoma	0.000618	0.00428	CcSEcCtD
Benzphetamine—Urticaria—Dorzolamide—glaucoma	0.000609	0.00421	CcSEcCtD
Benzphetamine—Dizziness—Bimatoprost—glaucoma	0.0006	0.00415	CcSEcCtD
Benzphetamine—Urticaria—Brinzolamide—glaucoma	0.000599	0.00414	CcSEcCtD
Benzphetamine—Hypersensitivity—Brimonidine—glaucoma	0.000592	0.00409	CcSEcCtD
Benzphetamine—Headache—Apraclonidine—glaucoma	0.000586	0.00405	CcSEcCtD
Benzphetamine—Tremor—Betaxolol—glaucoma	0.000578	0.004	CcSEcCtD
Benzphetamine—Diarrhoea—Acetazolamide—glaucoma	0.000572	0.00396	CcSEcCtD
Benzphetamine—Headache—Bimatoprost—glaucoma	0.000568	0.00393	CcSEcCtD
Benzphetamine—Hypersensitivity—Dorzolamide—glaucoma	0.000565	0.00391	CcSEcCtD
Benzphetamine—Tachycardia—Clonidine—glaucoma	0.000565	0.0039	CcSEcCtD
Benzphetamine—Hypersensitivity—Travoprost—glaucoma	0.000563	0.00389	CcSEcCtD
Benzphetamine—Hyperhidrosis—Clonidine—glaucoma	0.000559	0.00387	CcSEcCtD
Benzphetamine—Nausea—Apraclonidine—glaucoma	0.000556	0.00384	CcSEcCtD
Benzphetamine—Hypersensitivity—Brinzolamide—glaucoma	0.000555	0.00384	CcSEcCtD
Benzphetamine—Dizziness—Acetazolamide—glaucoma	0.000553	0.00383	CcSEcCtD
Benzphetamine—Anorexia—Clonidine—glaucoma	0.000552	0.00381	CcSEcCtD
Benzphetamine—Palpitations—Betaxolol—glaucoma	0.000545	0.00377	CcSEcCtD
Benzphetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000545	0.00957	CbGpPWpGaD
Benzphetamine—Nausea—Bimatoprost—glaucoma	0.000539	0.00372	CcSEcCtD
Benzphetamine—Hypersensitivity—Pilocarpine—glaucoma	0.000534	0.00369	CcSEcCtD
Benzphetamine—Dizziness—Brimonidine—glaucoma	0.000531	0.00367	CcSEcCtD
Benzphetamine—Diarrhoea—Dorzolamide—glaucoma	0.000525	0.00363	CcSEcCtD
Benzphetamine—Headache—Acetazolamide—glaucoma	0.000524	0.00362	CcSEcCtD
Benzphetamine—Insomnia—Clonidine—glaucoma	0.000523	0.00362	CcSEcCtD
Benzphetamine—Diarrhoea—Travoprost—glaucoma	0.000522	0.00361	CcSEcCtD
Benzphetamine—Diarrhoea—Brinzolamide—glaucoma	0.000516	0.00357	CcSEcCtD
Benzphetamine—Dizziness—Dorzolamide—glaucoma	0.000507	0.00351	CcSEcCtD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000507	0.00891	CbGpPWpGaD
Benzphetamine—Dizziness—Travoprost—glaucoma	0.000505	0.00349	CcSEcCtD
Benzphetamine—Headache—Brimonidine—glaucoma	0.000503	0.00348	CcSEcCtD
Benzphetamine—Decreased appetite—Clonidine—glaucoma	0.000503	0.00348	CcSEcCtD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000501	0.0088	CbGpPWpGaD
Benzphetamine—Gastrointestinal disorder—Clonidine—glaucoma	0.0005	0.00345	CcSEcCtD
Benzphetamine—Dizziness—Brinzolamide—glaucoma	0.000499	0.00345	CcSEcCtD
Benzphetamine—Nausea—Acetazolamide—glaucoma	0.000497	0.00344	CcSEcCtD
Benzphetamine—Diarrhoea—Pilocarpine—glaucoma	0.000496	0.00343	CcSEcCtD
Benzphetamine—Tachycardia—Betaxolol—glaucoma	0.000492	0.0034	CcSEcCtD
Benzphetamine—Hyperhidrosis—Betaxolol—glaucoma	0.000487	0.00337	CcSEcCtD
Benzphetamine—Headache—Dorzolamide—glaucoma	0.00048	0.00332	CcSEcCtD
Benzphetamine—Anorexia—Betaxolol—glaucoma	0.00048	0.00332	CcSEcCtD
Benzphetamine—Dizziness—Pilocarpine—glaucoma	0.000479	0.00331	CcSEcCtD
Benzphetamine—Headache—Travoprost—glaucoma	0.000478	0.00331	CcSEcCtD
Benzphetamine—Nausea—Brimonidine—glaucoma	0.000477	0.0033	CcSEcCtD
Benzphetamine—Headache—Brinzolamide—glaucoma	0.000472	0.00327	CcSEcCtD
Benzphetamine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000462	0.00812	CbGpPWpGaD
Benzphetamine—Urticaria—Clonidine—glaucoma	0.00046	0.00318	CcSEcCtD
Benzphetamine—Insomnia—Betaxolol—glaucoma	0.000456	0.00315	CcSEcCtD
Benzphetamine—Nausea—Dorzolamide—glaucoma	0.000455	0.00315	CcSEcCtD
Benzphetamine—Headache—Pilocarpine—glaucoma	0.000454	0.00314	CcSEcCtD
Benzphetamine—Nausea—Travoprost—glaucoma	0.000454	0.00314	CcSEcCtD
Benzphetamine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000451	0.00793	CbGpPWpGaD
Benzphetamine—Nausea—Brinzolamide—glaucoma	0.000448	0.0031	CcSEcCtD
Benzphetamine—Palpitations—Timolol—glaucoma	0.000446	0.00308	CcSEcCtD
Benzphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000444	0.0078	CbGpPWpGaD
Benzphetamine—Dyspepsia—Betaxolol—glaucoma	0.000443	0.00307	CcSEcCtD
Benzphetamine—Decreased appetite—Betaxolol—glaucoma	0.000438	0.00303	CcSEcCtD
Benzphetamine—ADRA1A—AMPK Signaling—RPTOR—glaucoma	0.000435	0.00765	CbGpPWpGaD
Benzphetamine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000435	0.00301	CcSEcCtD
Benzphetamine—Nausea—Pilocarpine—glaucoma	0.00043	0.00298	CcSEcCtD
Benzphetamine—Hypersensitivity—Clonidine—glaucoma	0.000426	0.00295	CcSEcCtD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000417	0.00733	CbGpPWpGaD
Benzphetamine—Urticaria—Betaxolol—glaucoma	0.0004	0.00277	CcSEcCtD
Benzphetamine—Hyperhidrosis—Timolol—glaucoma	0.000398	0.00275	CcSEcCtD
Benzphetamine—Diarrhoea—Clonidine—glaucoma	0.000396	0.00274	CcSEcCtD
Benzphetamine—Anorexia—Timolol—glaucoma	0.000392	0.00271	CcSEcCtD
Benzphetamine—Dizziness—Clonidine—glaucoma	0.000383	0.00265	CcSEcCtD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000381	0.0067	CbGpPWpGaD
Benzphetamine—Insomnia—Timolol—glaucoma	0.000372	0.00257	CcSEcCtD
Benzphetamine—Hypersensitivity—Betaxolol—glaucoma	0.000371	0.00257	CcSEcCtD
Benzphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000367	0.00644	CbGpPWpGaD
Benzphetamine—Headache—Clonidine—glaucoma	0.000363	0.00251	CcSEcCtD
Benzphetamine—Dyspepsia—Timolol—glaucoma	0.000362	0.0025	CcSEcCtD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A13—glaucoma	0.000361	0.00635	CbGpPWpGaD
Benzphetamine—Decreased appetite—Timolol—glaucoma	0.000358	0.00247	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Timolol—glaucoma	0.000355	0.00246	CcSEcCtD
Benzphetamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000351	0.00617	CbGpPWpGaD
Benzphetamine—Diarrhoea—Betaxolol—glaucoma	0.000345	0.00238	CcSEcCtD
Benzphetamine—Nausea—Clonidine—glaucoma	0.000344	0.00238	CcSEcCtD
Benzphetamine—SLC6A3—Alpha-synuclein signaling—BAD—glaucoma	0.000344	0.00604	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000341	0.00599	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000338	0.00594	CbGpPWpGaD
Benzphetamine—ADRA1A—Endothelin Pathways—EDN1—glaucoma	0.000334	0.00586	CbGpPWpGaD
Benzphetamine—Dizziness—Betaxolol—glaucoma	0.000333	0.0023	CcSEcCtD
Benzphetamine—Urticaria—Timolol—glaucoma	0.000327	0.00226	CcSEcCtD
Benzphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000325	0.00571	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A13—glaucoma	0.00032	0.00562	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SLC6A13—glaucoma	0.00032	0.00562	CbGpPWpGaD
Benzphetamine—Headache—Betaxolol—glaucoma	0.000316	0.00218	CcSEcCtD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000305	0.00537	CbGpPWpGaD
Benzphetamine—Hypersensitivity—Timolol—glaucoma	0.000303	0.0021	CcSEcCtD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000302	0.00531	CbGpPWpGaD
Benzphetamine—Nausea—Betaxolol—glaucoma	0.000299	0.00207	CcSEcCtD
Benzphetamine—SLC6A2—NRF2 pathway—TXN—glaucoma	0.000296	0.00521	CbGpPWpGaD
Benzphetamine—Diarrhoea—Timolol—glaucoma	0.000282	0.00195	CcSEcCtD
Benzphetamine—ADRA1A—G alpha (q) signalling events—OPN4—glaucoma	0.000278	0.00489	CbGpPWpGaD
Benzphetamine—Dizziness—Timolol—glaucoma	0.000272	0.00188	CcSEcCtD
Benzphetamine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000265	0.00466	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A1—glaucoma	0.000264	0.00464	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TXN—glaucoma	0.000263	0.00462	CbGpPWpGaD
Benzphetamine—Headache—Timolol—glaucoma	0.000258	0.00178	CcSEcCtD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000258	0.00453	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000257	0.00451	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—PTGFR—glaucoma	0.000251	0.0044	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000249	0.00437	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000249	0.00437	CbGpPWpGaD
Benzphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000247	0.00435	CbGpPWpGaD
Benzphetamine—Nausea—Timolol—glaucoma	0.000244	0.00169	CcSEcCtD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000235	0.00413	CbGpPWpGaD
Benzphetamine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000234	0.00412	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A1—glaucoma	0.000234	0.00411	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—SLC6A1—glaucoma	0.000234	0.00411	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000228	0.004	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000227	0.00399	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000224	0.00394	CbGpPWpGaD
Benzphetamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000223	0.00392	CbGpPWpGaD
Benzphetamine—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00022	0.00386	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000219	0.00384	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.000217	0.00381	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—TGFB2—glaucoma	0.000215	0.00379	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000215	0.00378	CbGpPWpGaD
Benzphetamine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000212	0.00373	CbGpPWpGaD
Benzphetamine—ADRA1A—Endothelin Pathways—NOS3—glaucoma	0.000203	0.00357	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000202	0.00354	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.0002	0.00351	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000194	0.0034	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—TGFB2—glaucoma	0.000191	0.00335	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SLC6A13—glaucoma	0.000191	0.00335	CbGpPWpGaD
Benzphetamine—SLC6A2—Monoamine Transport—TNF—glaucoma	0.000188	0.0033	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000184	0.00324	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000182	0.0032	CbGpPWpGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000181	0.00317	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00018	0.00316	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000173	0.00305	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000172	0.00302	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000171	0.00301	CbGpPWpGaD
Benzphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000167	0.00293	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—TNF—glaucoma	0.000166	0.00292	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000166	0.00292	CbGpPWpGaD
Benzphetamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000159	0.0028	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000154	0.00271	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000154	0.0027	CbGpPWpGaD
Benzphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000148	0.00259	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—GSTM1—glaucoma	0.000146	0.00257	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—OPN4—glaucoma	0.00014	0.00247	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—SLC6A1—glaucoma	0.000139	0.00245	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—OPN4—glaucoma	0.00013	0.00229	CbGpPWpGaD
Benzphetamine—SLC6A3—NRF2 pathway—GSTM1—glaucoma	0.00013	0.00228	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	0.000126	0.00222	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000126	0.00221	CbGpPWpGaD
Benzphetamine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000125	0.0022	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTT1—glaucoma	0.00012	0.00212	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—PTGFR—glaucoma	0.000117	0.00206	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000116	0.00203	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000102	0.0018	CbGpPWpGaD
Benzphetamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000101	0.00178	CbGpPWpGaD
Benzphetamine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.99e-05	0.00176	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	9.85e-05	0.00173	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—CYP1B1—glaucoma	9.59e-05	0.00169	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	9.46e-05	0.00166	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA5A—glaucoma	9e-05	0.00158	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NARFL—glaucoma	9e-05	0.00158	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.46e-05	0.00149	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NARFL—glaucoma	8.44e-05	0.00148	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA5A—glaucoma	8.44e-05	0.00148	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	8.33e-05	0.00146	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.21e-05	0.00144	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	7.93e-05	0.00139	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—GSTM1—glaucoma	7.67e-05	0.00135	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	7.56e-05	0.00133	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.5e-05	0.00132	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SOD1—glaucoma	7.46e-05	0.00131	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	7.45e-05	0.00131	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—OPN4—glaucoma	7.37e-05	0.0013	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—OPN4—glaucoma	7.2e-05	0.00127	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	7.14e-05	0.00126	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—OPN4—glaucoma	6.69e-05	0.00118	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PTGFR—glaucoma	6.63e-05	0.00117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	6.48e-05	0.00114	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—SMO—glaucoma	6.37e-05	0.00112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LRP12—glaucoma	6.14e-05	0.00108	CbGpPWpGaD
Benzphetamine—ADRA1A—AMPK Signaling—TP53—glaucoma	6.13e-05	0.00108	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	6.02e-05	0.00106	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—SMO—glaucoma	5.92e-05	0.00104	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LRP12—glaucoma	5.7e-05	0.001	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—C3—glaucoma	5.63e-05	0.00099	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.52e-05	0.00097	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.47e-05	0.000962	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	5.19e-05	0.000913	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.13e-05	0.000901	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB2—glaucoma	5.08e-05	0.000892	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.82e-05	0.000847	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.48e-05	0.000787	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA1—glaucoma	4.39e-05	0.000772	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.36e-05	0.000766	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.3e-05	0.000756	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CTSA—glaucoma	4.26e-05	0.000748	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—OPN4—glaucoma	4.25e-05	0.000748	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—EDN1—glaucoma	4.2e-05	0.000738	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA1—glaucoma	4.12e-05	0.000724	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CA2—glaucoma	4.02e-05	0.000706	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CTSA—glaucoma	3.99e-05	0.000701	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HEYL—glaucoma	3.96e-05	0.000695	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—OPN4—glaucoma	3.95e-05	0.000695	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—EDN1—glaucoma	3.9e-05	0.000686	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SOD1—glaucoma	3.85e-05	0.000676	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA5A—glaucoma	3.83e-05	0.000674	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NARFL—glaucoma	3.83e-05	0.000674	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTGFR—glaucoma	3.83e-05	0.000673	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CA2—glaucoma	3.77e-05	0.000662	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HEYL—glaucoma	3.67e-05	0.000646	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—C3—glaucoma	3.67e-05	0.000645	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTGFR—glaucoma	3.56e-05	0.000626	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.48e-05	0.000612	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.44e-05	0.000604	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—C3—glaucoma	3.41e-05	0.000599	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—SMO—glaucoma	3.27e-05	0.000575	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—SMO—glaucoma	3.04e-05	0.000534	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RPTOR—glaucoma	3e-05	0.000527	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	2.97e-05	0.000522	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MMP1—glaucoma	2.93e-05	0.000516	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NCK2—glaucoma	2.9e-05	0.00051	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TXN—glaucoma	2.83e-05	0.000498	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—CAV1—glaucoma	2.81e-05	0.000494	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RPTOR—glaucoma	2.78e-05	0.00049	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NCK2—glaucoma	2.7e-05	0.000474	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—FN1—glaucoma	2.68e-05	0.00047	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TXN—glaucoma	2.66e-05	0.000467	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	2.47e-05	0.000434	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	2.37e-05	0.000417	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	2.29e-05	0.000403	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	2.21e-05	0.000388	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTT1—glaucoma	2.2e-05	0.000386	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	2.16e-05	0.000379	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS3—glaucoma	2.13e-05	0.000374	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—C3—glaucoma	2.07e-05	0.000364	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTT1—glaucoma	2.06e-05	0.000362	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	2e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SMO—glaucoma	1.93e-05	0.000339	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—C3—glaucoma	1.93e-05	0.000339	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—C3—glaucoma	1.88e-05	0.000331	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA1—glaucoma	1.87e-05	0.000329	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CTSA—glaucoma	1.81e-05	0.000319	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SMO—glaucoma	1.79e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	1.77e-05	0.000311	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—C3—glaucoma	1.75e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1B1—glaucoma	1.75e-05	0.000308	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCA1—glaucoma	1.75e-05	0.000308	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CA2—glaucoma	1.71e-05	0.000301	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	1.64e-05	0.000288	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1B1—glaucoma	1.64e-05	0.000288	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCA1—glaucoma	1.64e-05	0.000288	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—glaucoma	1.53e-05	0.000269	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGFR—glaucoma	1.52e-05	0.000266	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	1.44e-05	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGFR—glaucoma	1.41e-05	0.000248	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—glaucoma	1.4e-05	0.000246	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	1.34e-05	0.000235	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	1.33e-05	0.000233	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—glaucoma	1.31e-05	0.00023	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EDN1—glaucoma	1.27e-05	0.000224	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—glaucoma	1.24e-05	0.000217	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	1.23e-05	0.000217	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TXN—glaucoma	1.21e-05	0.000212	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDN1—glaucoma	1.18e-05	0.000208	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGF—glaucoma	1.17e-05	0.000206	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—glaucoma	1.16e-05	0.000204	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TP53—glaucoma	1.16e-05	0.000203	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—glaucoma	1.15e-05	0.000202	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAV1—glaucoma	1.14e-05	0.0002	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—C3—glaucoma	1.11e-05	0.000196	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGF—glaucoma	1.09e-05	0.000191	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—glaucoma	1.08e-05	0.00019	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAV1—glaucoma	1.07e-05	0.000188	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—glaucoma	1.04e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—C3—glaucoma	1.03e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CAV1—glaucoma	1.03e-05	0.00018	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FN1—glaucoma	9.77e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—BAD—glaucoma	9.65e-06	0.00017	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—glaucoma	9.62e-06	0.000169	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CAV1—glaucoma	9.53e-06	0.000168	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTT1—glaucoma	9.36e-06	0.000164	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FN1—glaucoma	9.07e-06	0.00016	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—BAD—glaucoma	8.97e-06	0.000158	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—glaucoma	8.62e-06	0.000152	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—glaucoma	8.08e-06	0.000142	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—glaucoma	7.89e-06	0.000139	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—glaucoma	7.76e-06	0.000136	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCA1—glaucoma	7.45e-06	0.000131	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1B1—glaucoma	7.45e-06	0.000131	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—glaucoma	7.39e-06	0.00013	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—glaucoma	7.21e-06	0.000127	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	6.72e-06	0.000118	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	6.24e-06	0.00011	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—glaucoma	6.23e-06	0.000109	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—glaucoma	5.96e-06	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—glaucoma	5.78e-06	0.000102	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	5.59e-06	9.82e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—glaucoma	5.27e-06	9.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	5.19e-06	9.13e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—glaucoma	4.9e-06	8.62e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAV1—glaucoma	4.86e-06	8.54e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TP53—glaucoma	4.22e-06	7.42e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TP53—glaucoma	3.92e-06	6.9e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—glaucoma	3.67e-06	6.46e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—glaucoma	3.36e-06	5.9e-05	CbGpPWpGaD
